{
    "success": true,
    "data": {
        "leverage": false,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [
            "Use of OTC derivatives for index exposure",
            "Counterparty risk",
            "Potential for synthetic replication"
        ],
        "classification": "complex",
        "supporting_data": "The fund is a UCITS ETF, which establishes a presumption of non-complexity. However, this presumption is overturned by several factors outlined in the investment policy. The KIID states the fund may gain exposure to the index not only through 'direct investments' but also 'through the use of derivatives in particular where it may not be possible or practicable to replicate the index through direct investments'. This indicates that the replication method is not purely physical and can be synthetic or a hybrid.The use of derivatives is not limited to efficient portfolio management (EPM) but is integral to the investment strategy ('to generate efficiencies in gaining exposure to the index'). The KIID explicitly mentions the 'use of OTC derivatives' which 'engenders counterparty risk'. Under MiFID II, an instrument is considered complex if its structure and risks are not easily understood by a retail investor. The concepts of OTC derivatives, counterparty risk, and collateral policies are not straightforward. As the use of derivatives is central to achieving the fund's objective and introduces risks that are difficult to understand, the ETF is classified as complex. This aligns with the ESMA guidelines which treat instruments that embed a derivative or incorporate a structure making it difficult for a client to understand the risk involved as complex. The potential use of swaps or similar OTC derivatives to achieve index exposure is a definitive factor for a complex classification."
    }
}